As MAF forms a couplet with NRF2 and binds to the antioxidant response element (ARE) in the regulatory regions of target genes to promote the transcription of cytoprotective genes, the methylation of MAF and NRF2 could serve as potential therapeutic targets to treat the analyzed cancers in this study. The gene discussed is MAF; the disease is cancer.